Amdinocillin (CAS 32887-01-7)
QUICK LINKS
Amdinocillin, recognized for its targeted antibacterial properties, plays a role in the realm of microbiological research, particularly against gram-negative bacteria. This compound operates through a distinctive mechanism of action, inhibiting the synthesis of bacterial cell walls, thereby leading to bacterial cell lysis and ultimately, eradication of the infection. Its effectiveness hinges on its ability to bind to penicillin-binding proteins (PBPs) located in the bacterial cell membrane, which are essential for the cross-linking process that gives the cell wall its strength and rigidity. By disrupting this critical process, amdinocillin renders the bacteria incapable of maintaining their structural integrity, leading to their demise.
Amdinocillin (CAS 32887-01-7) References
- Amdinocillin (Mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coli. | Thulin, E., et al. 2015. Antimicrob Agents Chemother. 59: 1718-27. PMID: 25583718
- Amdinocillin treatment of catheter-associated bacteriuria in rabbits. | Olson, ME., et al. 1989. J Infect Dis. 159: 1065-72. PMID: 2656876
- Protective effect of amdinocillin against emergence of resistance to ceftazidime in Enterobacter cloacae. | Yourassowsky, E., et al. 1988. Antimicrob Agents Chemother. 32: 1632-5. PMID: 3075433
- Results from a Prospective In Vitro Study on the Mecillinam (Amdinocillin) Susceptibility of Enterobacterales. | Fuchs, F. and Hamprecht, A. 2019. Antimicrob Agents Chemother. 63: PMID: 30917983
- Amdinocillin: a novel penicillin. Antibacterial activity, pharmacology and clinical use. | Neu, HC. 1985. Pharmacotherapy. 5: 1-10. PMID: 3885172
- Amdinocillin: use alone or in combination with cefoxitin or carbenicillin-ticarcillin. | Lawson, RD., et al. 1983. Am J Med. 75: 113-8. PMID: 6310998
- Efficacy, pharmacology, and safety of amdinocillin in treatment of neonates. | de Louvois, J. and Mulhall, A. 1983. Am J Med. 75: 119-24. PMID: 6310999
- Morphologic changes produced by amdinocillin alone and in combination with beta-lactam antibiotics: in vitro and in vivo. | Kramer, MJ., et al. 1983. Am J Med. 75: 30-41. PMID: 6311003
- Amdinocillin therapy of experimental animal infections. | Gordin, FM. and Sande, MA. 1983. Am J Med. 75: 48-53. PMID: 6311005
- Amdinocillin pharmacokinetics. Simultaneous administration with cephalothin and cerebrospinal fluid penetration. | Gambertoglio, JG., et al. 1983. Am J Med. 75: 54-9. PMID: 6311006
- Review of clinical experience with amdinocillin monotherapy and comparative studies. | Demos, CH. and Green, E. 1983. Am J Med. 75: 72-81. PMID: 6311009
- Combination amdinocillin and cefoxitin therapy of multiply-resistant Serratia marcescens urinary tract infections. | Ward, TT., et al. 1983. Am J Med. 75: 85-9. PMID: 6311011
- Penicillin-binding proteins and role of amdinocillin in causing bacterial cell death. | Neu, HC. 1983. Am J Med. 75: 9-20. PMID: 6311012
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Amdinocillin, 1 g | sc-207277 | 1 g | $126.00 |